• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非阑尾结直肠癌腹膜癌病不完全可切除性的术前标准。

Preoperative criteria of incomplete resectability of peritoneal carcinomatosis from non-appendiceal colorectal carcinoma.

作者信息

Elias Dominique, Benizri Emmanuel, Vernerey Déwy, Eldweny Hany, Dipietrantonio Daniela, Pocard Marc

机构信息

Department of Surgical Oncology, Institut Gustave Roussy, Villejuif.

出版信息

Gastroenterol Clin Biol. 2005 Oct;29(10):1010-3. doi: 10.1016/s0399-8320(05)88175-8.

DOI:10.1016/s0399-8320(05)88175-8
PMID:16435508
Abstract

OBJECTIVE

To analyse the causes of non resectability of peritoneal carcinomatosis (PC) of non-appendiceal colorectal carcinomas, discovered only at the time of the laparotomy.

SUMMARY BACKGROUND DATA

The combination of a maximal cytoreductive surgery (resecting tumor deposits > 1 mm in diameter) with intraperitoneal chemohyperthermia results in cure a significant number of patients. Complete resection of the PC is the determining factor of this time-consuming and resource-consuming therapy. Unfortunately, it has not been possible, so far, to safely predict complete resectability before carrying out the laparotomy.

METHODS

All patients with colorectal PC who had undergone a laparotomy in order to receive this new treatment, but who finally presented a non completely resectable PC were included in our study. Their preoperative parameters were retrospectively studied and compared to matched number of patients who had successfully undergone this treatment.

RESULTS

29 patients had incomplete resection PC at laparotomy. They were compared with 29 matched patients who underwent a complete resection of the PC. The factors predicting non resectability were, in decreasing order of frequency: presence or persistence of an ascitis just before the laparotomy (P = 0.0008), progression of the PC while on neo-adjuvant chemotherapy (P = 0.01), abnormal CT- imaging (P = 0.03), and sub-occlusive syndrome (P = 0.05). These parameters were partially inter-related.

CONCLUSION

The persistence of ascitis and any progression of the disease while on chemotherapy are important predictive factors of incomplete resectability of non-appendiceal colorectal PC.

摘要

目的

分析非阑尾结直肠癌腹膜癌转移(PC)仅在剖腹手术时才被发现而无法切除的原因。

总结背景数据

最大程度的细胞减灭术(切除直径>1mm的肿瘤结节)与腹腔内热化疗相结合可使相当数量的患者治愈。PC的完全切除是这种耗时且资源消耗大的治疗方法的决定性因素。不幸的是,到目前为止,在进行剖腹手术前还无法安全地预测是否能完全切除。

方法

所有因接受这种新治疗而接受剖腹手术,但最终呈现无法完全切除的PC的结直肠癌PC患者均纳入本研究。对他们的术前参数进行回顾性研究,并与成功接受该治疗的匹配数量患者进行比较。

结果

29例患者在剖腹手术时PC切除不完全。将他们与29例接受PC完全切除的匹配患者进行比较。预测无法切除的因素,按频率递减顺序为:剖腹手术前存在或持续存在腹水(P = 0.0008)、新辅助化疗期间PC进展(P = 0.01)、CT成像异常(P = 0.03)和亚闭塞综合征(P = 0.05)。这些参数部分相互关联。

结论

腹水持续存在以及化疗期间疾病的任何进展是非阑尾结直肠癌PC无法完全切除的重要预测因素。

相似文献

1
Preoperative criteria of incomplete resectability of peritoneal carcinomatosis from non-appendiceal colorectal carcinoma.非阑尾结直肠癌腹膜癌病不完全可切除性的术前标准。
Gastroenterol Clin Biol. 2005 Oct;29(10):1010-3. doi: 10.1016/s0399-8320(05)88175-8.
2
Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.意外腹膜癌病是否仍然是结直肠肝转移切除的禁忌症?术中发现结直肠肝转移合并腹膜种植时的联合切除术。
Eur J Surg Oncol. 2013 Sep;39(9):981-7. doi: 10.1016/j.ejso.2013.06.009. Epub 2013 Jul 8.
3
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.减瘤手术联合围手术期腹腔内化疗治疗结直肠癌腹膜转移癌:一项多机构研究
J Clin Oncol. 2004 Aug 15;22(16):3284-92. doi: 10.1200/JCO.2004.10.012.
4
Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials.结直肠癌腹膜转移癌的治疗:完全细胞减灭术的影响及开展随机试验的困难
Ann Surg Oncol. 2004 May;11(5):518-21. doi: 10.1245/ASO.2004.09.008.
5
Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma.结直肠癌腹膜播散治疗的现状与未来方向
Surg Oncol Clin N Am. 2012 Oct;21(4):611-23. doi: 10.1016/j.soc.2012.07.014.
6
Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术和腹腔内热灌注化疗后高级别阑尾或结直肠腹膜癌转移进展的预测因素
Ann Surg Oncol. 2015 May;22(5):1716-21. doi: 10.1245/s10434-014-3985-y. Epub 2014 Aug 22.
7
Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis.术前计算机断层扫描不能预测腹膜癌病的可切除性。
Am J Surg. 2014 May;207(5):760-4; discussion 764-5. doi: 10.1016/j.amjsurg.2013.12.024. Epub 2014 Mar 12.
8
Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: Who will benefit from complete cytoreductive surgery?结直肠癌伴腹膜转移及肝同步转移患者:哪些人能从完全肿瘤细胞减灭术中获益?
Int J Surg. 2016 Jan;25:98-105. doi: 10.1016/j.ijsu.2015.11.025. Epub 2015 Dec 1.
9
Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.完整细胞减灭术联合奥沙利铂腹腔热灌注化疗治疗结直肠源性腹膜癌病
J Clin Oncol. 2009 Feb 10;27(5):681-5. doi: 10.1200/JCO.2008.19.7160. Epub 2008 Dec 22.
10
Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.结直肠癌源性腹膜癌转移:发病率及当前治疗策略
Ann Surg. 2006 Feb;243(2):212-22. doi: 10.1097/01.sla.0000197702.46394.16.

引用本文的文献

1
Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies-A Comprehensive Review.消化系统恶性肿瘤腹膜转移的手术治疗选择:全面综述。
Medicina (Kaunas). 2023 Jan 28;59(2):255. doi: 10.3390/medicina59020255.
2
Diagnostic and Therapeutic Algorithm for Appendiceal Tumors and Pseudomyxoma Peritonei: A Consensus of the Peritoneal Malignancies Oncoteam of the Italian Society of Surgical Oncology (SICO).阑尾肿瘤及腹膜假黏液瘤的诊断与治疗算法:意大利外科肿瘤学会(SICO)腹膜恶性肿瘤肿瘤治疗团队共识
Cancers (Basel). 2023 Jan 24;15(3):728. doi: 10.3390/cancers15030728.
3
Knowing When to Use Stereotactic Ablative Radiation Therapy in Oligometastatic Cancer.
了解何时在寡转移癌中使用立体定向消融放疗。
Cancer Manag Res. 2021 Sep 7;13:7009-7031. doi: 10.2147/CMAR.S294116. eCollection 2021.
4
The Characteristics of 206 Long-Term Survivors with Peritoneal Metastases from Colorectal Cancer Treated with Curative Intent Surgery: A Multi-Center Cohort from PSOGI.206例接受根治性手术治疗的结直肠癌腹膜转移长期生存者的特征:来自PSOGI的多中心队列研究
Cancers (Basel). 2021 Jun 13;13(12):2964. doi: 10.3390/cancers13122964.
5
Tumor Control and Overall Survival after Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: A Meta-Analysis.立体定向体部放疗治疗结直肠癌肺寡转移后的肿瘤控制和总生存:一项Meta分析
Cancer Res Treat. 2020 Oct;52(4):1188-1198. doi: 10.4143/crt.2020.402. Epub 2020 Jul 21.
6
CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival.结直肠癌继发腹膜转移患者的CRS和HIPEC:小肠PCI评分作为生存预测指标
Pleura Peritoneum. 2019 Oct 30;4(4):20190018. doi: 10.1515/pp-2019-0018. eCollection 2019 Dec 1.
7
Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.结直肠或阑尾肿瘤所致腹膜表面恶性肿瘤患者的细胞减灭术及腹腔内热灌注化疗应用指南。
Curr Oncol. 2015 Apr;22(2):e100-12. doi: 10.3747/co.22.2058.
8
Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.小肠受累是接受完全细胞减灭术加腹腔热灌注化疗治疗的结直肠癌腹膜转移患者的预后因素。
World J Surg Oncol. 2012 Apr 11;10:56. doi: 10.1186/1477-7819-10-56.
9
Inguinal herniae: Valuable clues to concurrent abdominal pathology: A series of case studies describing unusual findings in 'routine' hernia operations which demonstrate the need for thorough surgical training.腹股沟疝:并发腹部病变的重要线索:一系列病例研究描述了“常规”疝手术中的异常发现,这些发现表明需要进行全面的外科培训。
Int J Surg Case Rep. 2011;2(7):198-200. doi: 10.1016/j.ijscr.2011.05.006. Epub 2011 Jun 25.
10
Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.与腹腔内热灌注化疗相关的迭代细胞减灭术用于治疗有或无肝转移的结直肠源性腹膜癌病。
Ann Surg. 2007 Apr;245(4):597-603. doi: 10.1097/01.sla.0000255561.87771.11.